SARGENT INVESTMENT GROUP, LLC – Matinas BioPharma Holdings, Inc. Transaction History
SARGENT INVESTMENT GROUP, LLC portfolio value:
$2.90M
portfolio value
SARGENT INVESTMENT GROUP, LLC quarter portfolio value change:
-19.49%
quarter
Matinas BioPharma Holdings, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +6.22% | 246.43K shares | -226K | $0.64 | 4.20M |
| Q2 2022 | share | Increase | +8.70% | 316.92K shares | 198K | $0.79 | 3.96M |
| Q1 2022 | share | Increase | +0.42% | 15.07K shares | -734K | $0.8 | 3.64M |
| Q4 2021 | share | Increase | +11.83% | 383.88K shares | -554K | $1.03 | 3.62M |
| Q3 2021 | share | Increase | +47.88% | 1.05M shares | 2.51M | $1.3 | 3.24M |
| Q2 2021 | share | Increase | +9.23% | 185.40K shares | -409K | $0.77 | 2.19M |
| Q1 2021 | share | Increase | +40.53% | 579.46K shares | 165K | $1.05 | 2.00M |
| Q4 2020 | share | Increase | +85.06% | 657.04K shares | 1.35M | $1.36 | 1.42M |
| Q3 2020 | share | Increase | +145.58% | 457.93K shares | 346K | $0.77 | 772.48K |
| Q2 2020 | share | Increase | +63.79% | 122.5K shares | 131K | $0.77 | 314.55K |
| Q1 2020 | share | Increase | +243.87% | 136.2K shares | -12K | $0.6 | 192.05K |
| Q4 2019 | share | Increase | 0.00% | 55.85K shares | 127K | $2.27 | 55.85K |